Revolutionary Sepsis Treatment Moves to Next Phase of Human Trials

Vectorial Adaptive Optics: A New Horizon in Phase and Polarization Correction

Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses

Titan Dragonfly is Go!…. for Phase C